Wealthcare Advisory Partners’s Avantis Emerging Markets ex-China Equity ETF AVXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.9M Buy
132,164
+3,560
+3% +$289K 0.18% 113
2026
Q2
$11M Sell
128,604
-5,350
-4% -$426K 0.21% 96
2026
Q1
$9.06M Buy
133,954
+25,309
+23% +$1.76M 0.18% 120
2025
Q4
$6.93M Buy
108,645
+12,437
+13% +$773K 0.14% 138
2025
Q3
$5.77M Buy
96,208
+24,770
+35% +$1.43M 0.12% 147
2025
Q2
$4.04M Sell
71,438
-318
-0.4% -$16.5K 0.09% 181
2025
Q1
$3.49M Buy
+71,756
New +$3.56M 0.09% 186

Other funds holding AVXC

Wealthcare Advisory Partners's AVXC Position: Q3 2026 in Review

Wealthcare Advisory Partners increased its Avantis Emerging Markets ex-China Equity ETF (AVXC) stake by 2.8% in Q3 2026, buying an estimated $289K and bringing the position to 132,164 shares worth $10.9M. The position accounts for 0.18% of the portfolio, ranked #113.

Wealthcare Advisory Partners first reported a position in AVXC in Q1 2025 and has held it in 7 quarters since. The position peaked at $11M in Q2 2026. 43 funds tracked by Wall St. Rank hold AVXC as of Q3 2026.

  • Wealthcare Advisory Partners held 132,164 shares of Avantis Emerging Markets ex-China Equity ETF worth $10.9M as of Q3 2026.
  • Wealthcare Advisory Partners bought 3,560 Avantis Emerging Markets ex-China Equity ETF shares in Q3 2026, an estimated $289K.
  • Avantis Emerging Markets ex-China Equity ETF made up 0.18% of Wealthcare Advisory Partners's portfolio in Q3 2026, its #113 holding.
  • Wealthcare Advisory Partners first reported a position in Avantis Emerging Markets ex-China Equity ETF in Q1 2025 and has held it in 7 quarters since.
  • Wealthcare Advisory Partners's Avantis Emerging Markets ex-China Equity ETF position peaked at $11M in Q2 2026.
  • 43 funds tracked by Wall St. Rank held Avantis Emerging Markets ex-China Equity ETF as of Q3 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2026, filed 21 Oct 2026.